News & Media

Recipients of the Institute’s award for women postdocs met with Prof. Varda Rotter and philanthropic supporters to discuss science, work-life balance, and how the award reinforces the importance of encouraging talented female scientists.

May 08, 2012

May is Melanoma/Skin Cancer Detection and Prevention Month. Learn what the Weizmann Institute is doing to fight the most common form of cancer.

May 03, 2012

From: Haaretz

In another installment of the successful event known as “Science on Tap,” world-class scientists and top research students from the Weizmann Institute again raided Tel Aviv bars to talk of alternate realities, genetic engineering, and the fate of the universe.

May 01, 2012

A Weizmann team developed a photodynamic therapy that uses light to activate cancer-killing drugs and destroy cancer cells. The method was found to be efficient in curing melanoma with a success rate of 85 percent.

May 01, 2012

Prof. Avri Ben-Ze’ev has long studied the role of a gene called beta-catenin in various cancers, including identifying Nr-CAM, which is unleashed by beta-catenin’s signaling. Not previously known to play a role in cancer, Nr-CAM is dramatically elevated in colon cancer and melanoma cells.

April 30, 2012

Prof. Michel Revel of the Department of Molecular Genetics isolated interleukin-6, or IL-6, an immune system protein that can also play a role in cancer treatment.

April 30, 2012

From: Israel21c

Weizmann Institute neuroscientists have successfully enhanced memory in rats. Are humans next? Israel21c reports on the research and its implications.

April 22, 2012

Thanks to Weizmann research, a new and improved version of a detoxifying enzyme produced naturally by our livers may be able to protect us against otherwise deadly chemical attacks, such as Tokyo’s subway sarin incident that left 13 people dead and thousands more injured.

April 19, 2012

From:

April 08, 2012